Almitrine

RESPIRATORY SYSTEM

Key facts

Almitrine is a drug catalogued in DrugCentral. Recorded indications include Chronic obstructive lung disease.

• Indications: Chronic obstructive lung disease.
• ATC code: R07AB07 (Respiratory stimulants).
• Molecular formula: C26H29F2N7; molecular weight 477.56 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Chronic obstructive lung disease

ATC classification

ATC code	Therapeutic hierarchy
R07AB07	RESPIRATORY SYSTEM › OTHER RESPIRATORY SYSTEM PRODUCTS › OTHER RESPIRATORY SYSTEM PRODUCTS › Respiratory stimulants

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Lichenoid keratosis	89.0

Chemical structure

• Molecular formula: C₂₆H₂₉F₂N₇
• Molecular weight: 477.56 g/mol
• CAS number: 27469-53-0
• InChIKey: OBDOVFRMEYHSQB-UHFFFAOYSA-N
• PubChem CID: 33887

FC1=CC=C(C=C1)C(N1CCN(CC1)C1=NC(NCC=C)=NC(NCC=C)=N1)C1=CC=C(F)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Almitrine used for?

DrugCentral lists the following indications for Almitrine: Chronic obstructive lung disease.

What is the chemical formula of Almitrine?

Almitrine has the molecular formula C26H29F2N7 and a molecular weight of 477.56 g/mol.

Sources

• DrugCentral drug card 127 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1183717 — compound record and bioactivity
• PubChem CID 33887 — chemical identifiers
• DrugBank DB01430 — drug record
• FDA UNII 9A1222NBG4 — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.